This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Andersons (ANDE) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Andersons (ANDE) delivered earnings and revenue surprises of 43.40% and 3.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
4 Agriculture - Products Stocks to Watch in a Challenging Industry
by Madhurima Das
Despite the Agriculture - Products industry facing elevated input costs and supply chain issues, stocks like Bunge (BG), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA) are poised well to withstand the same.
Zacks Industry Outlook Highlights Bunge, CalMaine Foods and Arcadia Biosciences
by Zacks Equity Research
Bunge, CalMaine Foods and Arcadia Biosciences are part of the Zacks Industry Outlook article.
3 Stocks to Watch in the Promising Agriculture - Products Industry
by Madhurima Das
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
3 Stocks Worth a Look in the Thriving Agriculture - Products Industry
by Madhurima Das
With the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Arcadia Biosciences (RKDA) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 36.84% and 43.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Hecla Mining (HL) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Hecla Mining (HL) delivered earnings and revenue surprises of 50% and 12.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GrowGeneration (GRWG) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
GrowGeneration (GRWG) delivered earnings and revenue surprises of 0% and 23.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
The Andersons (ANDE) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Andersons (ANDE) delivered earnings and revenue surprises of 51.52% and 34.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Bunge (BG) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Bunge (BG) delivered earnings and revenue surprises of 41.39% and 7.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for October 24th
by Zacks Equity Research
BXRX, WOLF, GHRS, RKDA and BHR have been added to the Zacks Rank #1 (Strong Buy) List on October 24, 2022.
3 Stocks to Watch in the Promising Agriculture - Products Industry
by Madhurima Das
With the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Arcadia Biosciences (RKDA) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Marijuana ETFs & Stocks Have More Room to Run
by Sanghamitra Saha
Marijuana stocks and ETFs are hot this year and can perform better in the coming days.
Why These Pharma ETFs Rallied on Thursday
by Sanghamitra Saha
A few pharma ETFs hit a one-month high on Feb 28. Why?
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 59.29% and 42.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.